Jiahong Zhu

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial

Jingxin Li, Lihua Hou, Xiling Guo et al. · Nature Medicine · 2022 · 158 citations · Full text

Nanobody-horseradish peroxidase fusion protein as an ultrasensitive probe to detect antibodies against Newcastle disease virus in the immunoassay

Yamin Sheng, Kun Wang, Qizhong Lu et al. · Journal of Nanobiotechnology · 2019 · 83 citations · Full text

Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial

Fengcai Zhu, Shangying Hu, Ying Hong et al. · Cancer Medicine · 2019 · 56 citations · Full text

Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial

Rong Tang, Hui Zheng, Busen Wang et al. · The Lancet Respiratory Medicine · 2023 · 48 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

Efficacy, immunogenicity, and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in Chinese women aged 18–25 years: event‐triggered analysis of a randomized controlled trial

Fengcai Zhu, Shangying Hu, Ying Hong et al. · Cancer Medicine · 2016 · 42 citations · Full text